title: Assessing health economic outcome in Alzheimer's disease clinical trials.
abstract: This paper reviews methodological considerations in collecting data on economic endpoints and conducting economic evaluation alongside clinical trials in Alzheimer's disease (AD).
authors.affiliation: L. Jonsson, European Health Economics, Stockholm, Sweden.
authors.forename: L
authors.initials: L
authors.lastname: Jonsson
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000191:economics*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D003657:Decision Making; D017048:Health Care Costs; D006801:Humans; D018697:Nootropic Agents / Q000191:economics* / Q000627:therapeutic use*; D017063:Outcome Assessment, Health Care
chemical_list: D018697:Nootropic Agents